Compared to CD39−CD8+ TILs, CD39+CD8+ TILs exhibited features of proliferation, activation, and T cell-mediated cytotoxicity, alongside reduced TCR clonal diversity and increased TCR clonal expansion, indicating tumor reactivity. The gene discussed is CD8A; the disease is neoplasm.